Flow cytometry for the development of CGT assays: an interview with Richard Cuthbert

Cell and gene therapies Interviews

In this In the Zone podcast, we explore with Richard Cuthbert, Global Commercialization Product Manager Flow and Antibody Business at Bio-Rad (UK), the utilization of flow cytometry for cell and gene therapy (CGT) assay development and how these assays compare with other types of assays for CGT development.

Questions

1. What are the basics of flow cytometry and how are they currently utilized in the bioanalytical industry?
2. How do flow cytometric assays compare with other types of assays for CGT development?
3. When screening for potential therapeutic candidates, what does flow cytometry offer over traditional methods of lead discovery?
4. What challenges are associated with flow cytometry in drug discovery?
5. As a research tool, where else is flow cytometry making significant contributions?

In association with: